ABSI — Absci Corp
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1672688 ·
Last close
$5.28
Market Cap
$823.18M
52W High
$6.72
52W Low
$2.24
ADV30
4,945,606
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 215,000 | — | -30,846,000 | -29,599,000 | 195,593,000 | 8,627,000 | 23,622,000 |
| Dec 2025 | 650,000 | — | -36,142,000 | -29,562,000 | 216,297,000 | 20,025,000 | 26,848,000 |
| Sep 2025 | 378,000 | — | -30,154,000 | -28,706,000 | 244,992,000 | 9,476,000 | 34,652,000 |
| Jun 2025 | 593,000 | — | -31,393,000 | -30,569,000 | 209,892,000 | 38,024,000 | 36,519,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-92,925,000
Investing CF
$-50,160,000
Financing CF
$105,949,000
CapEx
$-1,233,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.85
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-624,784,000
Inventory
—
Receivables
$1,000,000
ST Investments
$124,267,000
EBIT TTM
$-114,905,000
Pretax Income TTM
$-115,114,000
Interest Exp TTM
$209,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,836,000
EBITDA
$-116,437,000
Free Cash Flow
$-41,475,376
Enterprise Value
$700,329,664
Total Cash
$125,705,000
Total Debt
$4,415,000
Shares Out
155,905,056
Trailing EPS
$-0.82
Book Value
$1.11
ROE
-63.9%
ROA
-37.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,800,000 | -125,418,000 | -115,183,000 | 216,297,000 | 26,848,000 | — | -92,925,000 |
| Dec 2024 | 4,534,000 | -108,888,000 | -103,106,000 | 213,608,000 | 34,475,000 | — | -72,402,000 |
| Dec 2023 | 5,718,000 | -94,180,000 | -110,566,000 | 217,298,000 | 41,122,000 | — | -64,636,000 |
| Dec 2022 | 5,747,000 | -106,750,000 | -104,904,000 | 321,008,000 | 46,594,000 | — | -81,339,000 |
TTM Snapshot
Revenues TTM
$1,701,000
NetIncome TTM
$-27,398,000
OpCashFlow TTM
$0
Assets (Latest)
$213,608,000
Forward EPS
$-0.62
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| QDEL | QuidelOrtho Corp | $817.61M | $11.99 | — |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $468.13M | $4.56 | — |
| NNNN | Anbio Biotechnology | $1.45B | $33.01 | — |
| NRC | NRC HEALTH | $429.10M | $19.04 | — |
| NTLA | Intellia Therapeutics, Inc. | $1.76B | $12.61 | — |
News headlines (Yahoo Finance, 1h cache)
The 1 AI Stock I'd Put in a Time Capsule and Open in 2036
2026-05-26 02:20 · Yahoo
Absci Insider Buyers Pleased With US$700k Return On Investment
2026-05-20 19:24 · Yahoo
Absci to Participate in Upcoming Investor Conferences
2026-05-20 12:00 · Yahoo
Marvell Stock Climbs After AMD Reveals Surprise Stake
2026-05-13 15:11 · Yahoo
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
2026-05-08 02:25 · Yahoo
Absci (ABSI) Q1 2026 Earnings Call Transcript
2026-05-07 22:50 · Yahoo
Absci Q1 Earnings Call Highlights
2026-05-07 22:39 · Yahoo
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
2026-05-07 20:05 · Yahoo
Recursion Pharmaceuticals Q1 Earnings Call Highlights
2026-05-06 20:42 · Yahoo
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-05-05 00:11 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.